glucagon + exenatide

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Suspension formulations of insulinotropic peptides and uses thereof
US 8299025 B2申请人: ALESSI THOMAS R优先权: 2007
CN
US
9 件公开
GLP-1 receptor modulators
- US 8778923 B2
  申请人: RECEPTOS INC优先权: 2012
  CN
  US
  5 件公开
- US 9260427 B2
  申请人: RECEPTOS INC优先权: 2014
  US
  2 件公开
A METHOD FOR REVERSING AGING BRAIN FUNCTIONAL DECLINE
EP 4262873 A4申请人: UNIV HONG KONG CHINESE优先权: 2020
EP
US
WO
3 件公开
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US 2012208755 A1申请人: LEUNG KARLING ALICE优先权: 2012
US
3 件公开
DRUG COCKTAIL FOR TREATMENT OF PARKINSON'S DISEASE, LEWY BODY DISEASE AND MULTIPLE SYSTEM ATROPHY
US 2024058288 A1申请人: ALETA NEUROSCIENCE LLC优先权: 2021
US
WO
2 件公开
COMBINATION THERAPY FOR TREATING NEURODEGENERATIVE DISORDERS
WO 2025104674 A1申请人: ARIBIO CO LTD优先权: 2023
CN
WO
2 件公开
COMPOSITIONS FOR DRUG ADMINISTRATION
US 2012021980 A1申请人: MAGGIO EDWARD T优先权: 2011
US
Novel GLP-1 receptor modulators
CN 112457301 A申请人: CELGENE INT II SARL优先权: 2014
CN
Modified glucagon-like peptide (GLP)-1 and application of modified compound of modified GLP-1
CN 107281471 A申请人: UNIV CHINA PHARMA优先权: 2017
CN
Polypeptide or protein nanoparticles based on hydrogen-bonded complexation, and preparation method and application thereof
CN 109224081 A申请人: UNIV SUN YAT SEN优先权: 2018
CN